Show simple item record

AuthorAbedin Zadeh M.
AuthorKhoder M.
AuthorAl-Kinani A.A.
AuthorYounes H.M.
AuthorAlany R.G.
Available date2020-04-27T08:34:19Z
Publication Date2019
Publication NameDrug Discovery Today
ResourceScopus
ISSN13596446
URIhttp://dx.doi.org/10.1016/j.drudis.2019.04.009
URIhttp://hdl.handle.net/10576/14551
AbstractDegenerative retinal diseases, such as age-related macular degeneration (AMD), can lead to permanent sight loss. Although intravitreal anti-vascular endothelial growth factor (VEGF) and steroid injections are effective for the management of early stages of wet and/or neovascular AMD (nAMD), no proven treatments currently exist for dry AMD or for the advanced geographic atrophy of the retina that follows. Tissue engineering (TE) has recently emerged as a promising alternative to repair retinal damaged and restore its functions. Here, we review recent advances in TE, with a particular emphasis on retinal regeneration. We provide an overview of retinal diseases, followed by a comprehensive review of TE techniques, cells, and polymers used in the fabrication of scaffolds for retinal cell regenerations, in particular the retinal pigment epithelium (RPE). - 2019
Languageen
PublisherElsevier Ltd
SubjectRetinal Pigment Epithelium
Stem Cells
Subretinal space
TitleRetinal cell regeneration using tissue engineered polymeric scaffolds
TypeArticle Review
Pagination1669-1678
Issue Number8
Volume Number24


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record